Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/12/2024 | $109.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $99.00 | Underweight | Barclays |
| 4/11/2024 | $106.00 → $120.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 4/8/2024 | $92.00 → $114.00 | Sell → Hold | TD Cowen |
| 1/8/2024 | $95.00 → $105.00 | Equal Weight → Underweight | Wells Fargo |
| 1/4/2024 | $88.00 | Underperform | TD Cowen |
| 10/31/2023 | $100.00 → $95.00 | Sell → Neutral | Citigroup |
| 5/19/2023 | $98.00 | Sell | Citigroup |
144 - PRICE T ROWE GROUP INC (0001113169) (Subject)
8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)
10-Q - PRICE T ROWE GROUP INC (0001113169) (Filer)
Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00
Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00
Keefe Bruyette upgraded T. Rowe Price from Underperform to Mkt Perform and set a new price target of $120.00 from $106.00 previously
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
New York, New York, June 18, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for the private senior debt financing supporting the acquisition of Tyber Medical, LLC ("Tyber Medical") by Montagu Private Equity ("Montagu"). Tyber Medical is a leading orthopedic device manufacturer serving the spine and trauma end markets. As part of the transaction, Montagu will merge Tyber Medical with two of its existing portfolio companies, Resolve Surgical Technologies ("Resolve") and Intech Medical ("Intech"), to create a scaled contract development and manufacturing organization ("CDMO") offering end-to-end services that span product conceptua
The T. Rowe Price Financials ETF, Health Care ETF and Natural Resources ETF began trading today and expanded the firm's ETF lineup to 22 BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds (ETF): T. Rowe Price Financials ETF (Ticker: TFNS), T. Rowe Price Health Care ETF (Ticker: TMED), and T. Rowe Price Natural Resources ETF (Ticker: TURF). The new funds began trading on NASDAQ today. T. Rowe Price's active ETF roster now sits at 22 offerings.
Investing in a post-globalization world with reconfigured global trade necessitates a careful assessment of market opportunities and risks BALTIMORE, June 9, 2025 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, released its midyear outlook for global financial markets for the remainder of 2025. Underpinning the outlook for the next six months is an accelerated trend toward deglobalization, a tariff-driven reconfiguration of global trade, an expected broadening of stock market opportunities globally beyond U.S. equities and mega-cap tech stocks, and a bond market regime change driven by trade policy changes and German fiscal expansion.
BALTIMORE, Nov. 1, 2024 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.24 per share payable December 27, 2024, to stockholders of record as of the close of business on December 13, 2024. ABOUT T. ROWE PRICEFounded in 1937, T. Rowe Price (NASDAQ – GS: TROW) helps individuals and institutions around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Clients rely on the award-winning f
BALTIMORE, July 30, 2024 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.24 per share payable September 27, 2024, to stockholders of record as of the close of business on September 13, 2024. ABOUT T. ROWE PRICEFounded in 1937, T. Rowe Price (NASDAQ – GS: TROW) helps individuals and institutions around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Clients rely on the award-winnin
New mutual fund adds to the T. Rowe Price Capital Appreciation suite and is led by award-winning portfolio manager David Giroux and Farris Shuggi BALTIMORE, Nov. 29, 2023 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the launch of the Capital Appreciation and Income Fund. The fund is an addition to the Capital Appreciation suite and seeks to generate strong risk-adjusted total returns through a combination of capital appreciation primarily from stocks, income from stock dividends, and interest income from the fund's fixed income holdings. The Capital Appreciation and Income Fund is one of three vehicles within the Capital Appreciation
BALTIMORE, May 9, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable June 27, 2025, to stockholders of record as of the close of business on June 13, 2025. Additionally, at its annual meeting yesterday, T. Rowe Price Group, Inc.'s stockholders: Elected 11 directors to its Board of Directors;Approved, by a nonbinding advisory vote, the compensation paid by the Company to its Named Executive Officers;Ratified the appointment of KPMG LLP as the Company's indepen
VANCOUVER, Wash., April 07, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ:BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., has appointed Mark S. Finn to its board of directors, effective April 7, 2025. Finn spent over 30 years with T. Rowe Price Group (NASDAQ:TROW), a global investment management firm, where he held several roles, including portfolio manager of the firm's $35 billion US Value Equity Strategy Fund and co-portfolio manager of its $3.5 billion US Large-Cap Value Equity Strategy Fund. Before T. Rowe Price, Finn worked in assurance services at Price Waterhouse & Co
DAVIDSON, N.C., April 03, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Michelle Swanenburg to its Board of Directors, effective immediately. Swanenburg currently serves as the head of Human Resources (HR) at T. Rowe Price (NASDAQ:TROW), a premier global asset management organization with $1.63 trillion in assets under management as of February 28, 2025. She brings over twenty years of experience as a strategic and accomplished HR leader, with a proven track record of leading growth and innovation by continually improving strategies focused on peop
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)